Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$40/share would be... "quite nice". XD
Uh-huh. And it's always "definitely a scam" unless we do. *eyeroll*
ROFL XD
Good article out today for anyone wanting an overview/refresher on Lexaria:
https://www.marketwatch.com/press-release/lexaria-bioscience-stock-rises-following-eba-to-conduct-exploratory-clinical-study-using-cannabidiol-for-blood-pressure-reduction-2020-08-17
Couldn't have said it better! XD
Who knows...
But it sure looks like something's going down this year - by hook or by crook.
With all the irons Lexy's got in the fire, and the uplisting, it will be really interesting to see how things unfold.
My impression has been more-or-less identical - i.e., little-to-no discernible flavor, and little-to-no discernible effect/benefit.
(Full disclosure: I was anxious to try it; so, I kinda just dove-in - I wasn't trying to address any aches, pains, anxiety, etc. at this time. So my "baseline" is probably not ideal/applicable for CBD use.)
I've tried it out in various flavors of cold seltzer water; has no difference in taste as far as I can tell.
Where would we be without him/her...?
Wow, thanks damAcon1 - love me a BOGO!
Grabbed 4 (total) - gonna try 'em with all sorts of things...
Asking out of ignorance: What is the significance (i.e., benefit) of turning-over the shareholder base?
New video:
Oh sweeeeett!!
Definitely a step up from the NNW puff pieces.
Lexy finally getting a piece of the spotlight...
Great find. Thanks for sharing!
CB elaborates here:
"WHAT YEAR IS THIS!??"
Hey - at least the news is "reasonably well-received" for once; doesn't happen all too often with Lexy.
Hmmmmmm... What are the odds this all sets Lexaria up for a nice "more-better Altria news plus uplist" play in October-ish, then, I wonder?
My take: "yes and no."
Yes: Basically, the Altria deal is still on. (EDIT: I think, in the balance, this makes it "good news" - yes - if your investment timeline is longer.)
No:
I hate to say it, but I agree - looks like this is the way they do business.
How do you figure? (Sorry - been outta-the-loop last couple weeks.)
Hopefully this is Bunka's gambit - i.e., a "revenue surprise coupled with an uplist" play a la ACB.
I genuinelyly doubt he's so naive as to think it's just a matter of "uplist and they will come" with the institutions... (Whether they promised this or not.)
He's been in this game long enough to know you have to show them some numbers too - good ones.
Also: He can't "sit on" any other material information, really, except for the earnings, which one can argue he gets to sit on until they're due to be released.
Alternatively, they're simply running out of money and it's just a straight-up Hail Mary; in which case, we're all royally screwed. XD
No surprise that somebody's sellin'... What's curious to me is that somebody's buyin'...!
"If I put ChrgD+ in my bourbon... Would the alcohol bypass my liver...?" XD
Putting the uplist pieces together...
I've made my point.
And it's finally sunk-in that I ought to take my own advice and stop entertaining your discontented, cynical ramblings - a waste of perfectly good time.
Whine away. It is your prerogative after all.
"Wrestling with a pig," Abundance88... Case in point:
If this is your central thesis, you should have even less to complain about - it means all you have to do is wait!
EDIT: Ughhhh... Never mind... Screw it - I'm done. Complain away. Like the wife says: "You can shit in one hand and pray/complain [she changes it depending on the occasion] in the other - see which fills-up first." But hey - whatever blows your hair back.
Ironic as I believe your befuddlement to be, I agree - to each their own.
Kickin' and screamin' about this or that and yet you're still here - whose fault is that?
One concern I have is that Gilead with be trying to - at best - strike a balance between ultimate utility (i.e., efficacy) and manufacturing cost.
(Yes - the first couple million doses are on them; but I doubt they will/can remain altruistic forever; and there's going to be plenty of need for the stuff.)
If they can find a way to make it "basically just as efficacious" in inhaled form as it is in pill form but augmented with third-party technology... well... Bob's your uncle insofar as Lexaria's involvement is concerned.
Gilead to begin human trials for the inhaled version of coronavirus drug remdesivir
Come the hell on Lexy - put the pedal to the metal...!!